| Literature DB >> 30611216 |
Naomi C Brownstein1,2, Jianwen Cai3.
Abstract
BACKGROUND: Many epidemiological studies test trends when investigating the association between a risk factor and a disease outcome. Continuous exposures are commonly discretized when the outcome is nonlinearly related to exposure as well as to facilitate interpretation and reduce measurement error. Guidance is needed regarding statistically valid trend tests for epidemiological data of this nature.Entities:
Keywords: Discretization; Linear regression; Power; Weighted least squares
Mesh:
Year: 2019 PMID: 30611216 PMCID: PMC6321711 DOI: 10.1186/s12874-018-0630-7
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Description of NHANES Data by BMI Class
| BMI Class | WHO Defined Lower Limit (kg/m2) | WHO Defined Upper Limit (kg/m2) | Number of Individuals | Unweighted Percent of Sample | WHO Defined Median (kg/m2) | Sample Median BMI (kg/m2) |
|---|---|---|---|---|---|---|
| Underweight | 12 | 18.5 | 93 | 1.7 | 17 | 17.8 |
| Normal Weight | 18.5 | 25 | 1513 | 27.3 | 23 | 22.7 |
| Overweight | 25 | 30 | 1919 | 34.6 | 28 | 27.5 |
| Obese | 30 | 70 | 2026 | 36.5 | 35 | 34.0 |
Values of bk for the Uniform Censoring Intervals (0,bk)
| Type 1 Error and Linear Alternatives | |||||
|---|---|---|---|---|---|
| k | pk | β = 0 | β = log (1.01) | β = log (1.05) | β = log (1.1) |
| 1 | 0.2 | 0.475 | 0.4 | 0.375 | 0.32 |
| 2 | 0.5 | 1.755 | 1.7 | 1.55 | 1.4 |
| 3 | 0.7 | 3.450 | 3.5 | 3.2 | 3.2 |
| Quadratic Alternatives | |||||
| k | pk | β = 0.001 | β = 0.002 | β = 0.003 | |
| 1 | 0.2 | 0.35 | 0.265 | 0.205 | |
| 2 | 0.5 | 1.35 | 1.12 | 0.95 | |
| 3 | 0.7 | 2.8 | 2.35 | 2.05 | |
Summary of Methods and Results: Type I Error and Power
| Method | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Weighted? | No | No | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Weights | N/A | N/A | N/A | ( | ( | ( | ( |
|
|
|
| Intercept? | No | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes |
| Reference Group included? | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | No | Yes |
| Type I Error Controlled? | No | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes |
| Power: Linear | N/A | M | L | VL | VL | H | M | N/A | H | M |
| Power: Weak Quadratic | N/A | H | M | L | L | M | M | N/A | M | H |
| Power: Strong Quadratic | N/A | M | L | VL | VL | H | M | N/A | H | H |
VL Very Low Power, L Low Power, M Moderate Power, H High Power
Relative amounts of power refer to the relative ranks of the methods. Methods classified as with high power had the most power for at least one scenario in the corresponding type of simulation. Methods classified as with medium or low power were ranked next. Methods classified with very low power displayed the lowest power in every simulation of that type
Fig. 1Simulated type I error rates for each method with binary outcomes by increasing intercept in Eq. (1), which in this case is equal to the log-odds of the event for a person with a BMI of 25 kg/m2.The dashed horizontal line at 0.05 indicates the significance level
Fig. 2Simulated type I error rates for each method by increasing prevalence with time-to-event outcomes, or equivalently, decreasing censoring. The dashed horizontal line at 0.05 indicates the significance level
Fig. 3Power for binary outcomes generated by Eq. (1) with a linear alternative of an odds ratio of 1.1 for a unit increase in BMI
Fig. 4Power for time-to event outcomes generated by Eq. (6) with a hazard ratio of 1.1 for a unit increase in BMI
Fig. 5Power for binary outcomes generated by Eq. (2) with β = 0.001. The setup denotes a weaker quadratic relationship between the log-odds of the event and increasing BMI
Fig. 6Power for time-to-event outcomes generated by Eq. (7) with β = 0.001. The setup denotes a weak quadratic relationship between the log-hazard ratio and BMI
Fig. 7Power for binary outcomes generated by Eq. (2) with β = 0.002. The setup denotes a moderate quadratic relationship between the log-odds of the event and BMI
Fig. 8Power for time-to-event outcomes generated by Eq. (7) with β = 0.002. The setup denotes a strong quadratic relationship between the log-hazard ratio and BMI
Fig. 9Power for binary outcomes generated by Eq. (2) with β = 0.003. The setup denotes a strong quadratic alternative, meaning the log-odds of the event increases quadratically with increasing BMI
Fig. 10Power for time-to-event outcomes generated by Eq. (7) with β = 0.003. The setup denotes a strong quadratic alternative in which the logarithm of the hazard ratio increases quadratically with increasing BMI
Fig. 11Power for binary outcomes generated by Eq. (1) with a linear alternative of an odds ratio of 1.01 for a unit increase in BMI. The setup denotes a weak linear alternative in which the log-odds of the event increases linearly but slowly with increasing BMI
Fig. 12Power for binary outcomes generated by Eq. (1) with a linear alternative of an odds ratio of 1.05 for a unit increase in BMI. The setup denotes a weak linear alternative in which the log-odds of the event increases linearly at a moderate rate with increasing BMI
Fig. 13Power for time-to event outcomes generated by Eq. (6) with a hazard ratio of 1.01 for a unit increase in BMI. The setup denotes a weak linear alternative in which the logarithm of the hazard ratio increases linearly but slowly with increasing BMI
Fig. 14Power for time-to event outcomes generated by Eq. (6) with a hazard ratio of 1.05 for a unit increase in BMI. The setup denotes a weak linear alternative in which the logarithm of the hazard ratio increases linearly at a moderate rate with increasing BMI
Cell Counts (and Weighteda Percentage) of Outcomes within Each Weight Class in the NHANES Dataset
| Outcome | Underweight | Normal Weight | Overweight | Obese | All |
|---|---|---|---|---|---|
| Diabetes Status | |||||
| No Diabetes | 92 (99.7) | 1406 (95.3) | 1699 (93.0) | 1563 (81.8) | 4760 (90.0) |
| Diabetes or Pre/Borderline | 1 (0.3) | 105 (4.7) | 219 (7.0) | 460 (18.2) | 785 (10.0) |
| Blood Pressure Status | |||||
| No High Blood Pressure | 74 (83.5) | 1153 (81.1) | 1275 (70.4) | 1050 (57.1) | 3552 (69.4) |
| High Blood Pressure | 19 (16.5) | 359 (18.9) | 642 (29.6) | 974 (42.9) | 1994 (30.6) |
aWeighted percentages take into account the sampling design used in NHANES
Conclusions of Trend Tests for the NHANES Dataset
| Outcome | Method | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diabetes or Pre/Border-line | P-value | N/A | 0.024 | 0.023 | 0.032 | 0.034 | 0.010 | 0.013 | N/A | 0.012 | 0.020 |
| Reject | N/A | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | |
| High Blood Pressure | P-value | N/A | 0.051 | 0.064 | 0.056 | 0.061 | 0.010 | 0.023 | N/A | 0.007 | 0.016 |
| Reject | N/A | No | No | No | No | Yes | Yes | N/A | Yes | Yes |
Yes = The null hypothesis of no trend was rejected at the 0.05 significance level
No = The null hypothesis of no trend was not rejected at the 0.05 significance level
Method 1: Unweighted, no intercept
Method 2: Unweighted, with intercept
Method 3: Unweighted, with intercept, reference group omitted
Method 4: Weighted by the inverse of Var (OR), with intercept
Method 5: Weighted by the inverse of SE (OR), with intercept
Method 6: Weighted by the inverse of Var (LogOR), with intercept
Method 7: Weighted by the inverse of SE (LogOR), with intercept
Method 8: Weighted by the sample size, no intercept
Method 9: Weighted by the sample size, with intercept, reference group omitted
Method 10: Weighted by the sample size, with intercept